Biologic Standards in the Pharmacopoeias: An Update Awareness of recently implemented-or ongoing-advances by the pharmacopoeias can help biotherapeutic manufacturers remain compliant with current requirements

Albanese, J. A.; Wiggins, J. M.

Albanese, J. A.; Wiggins, J. M..

BioPharm International ; 35(10):44-48, 2022.

Article in English | EMBASE | ID: covidwho-2218430

Keywords

bioequivalence; bioinformatics; carbon nuclear magnetic resonance; coronavirus disease 2019; drug manufacture; follow up; gene therapy; glycosylation; human; mass spectrometry; medical literature; note; phase 3 clinical trial (topic); phosp

Search on Google

XML

Collection: Databases of international organizations Database: EMBASE Language: English Journal: BioPharm International Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML

Collection: Databases of international organizations Database: EMBASE Language: English Journal: BioPharm International Year: 2022 Document Type: Article